Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes

Trial Profile

Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin suspension isophane
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms PREDICTIVE-BMI
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Jul 2009 Actual end date (1 Dec 2006) added as reported by ClinicalTrials.gov.
    • 08 Aug 2008 Results were published in Diabetic Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top